Stock ONCOLOGY VENTURE A/S
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Oncology Venture A/S Nasdaq Stockholm

Equities

End-of-day quote Nasdaq Stockholm
Other stock markets
- SEK - Intraday chart for Oncology Venture A/S
24/05 Allarity Therapeutics, Inc. Concludes Its Phase 2 Clinical Trial CI
06/05 Allarity Therapeutics Says Stockholders' Equity 'Significantly' Exceeds Nasdaq's $2.5 Million Minimum Rule MT

Chart calendar Oncology Venture A/S

09be1828b05e7cfbd7989.lP3OVV_TkbDkZqCZVX23fmFz-4Jt9TeGkoobPef8lvc.7K_jFzCj6IWnCcTcPxjaOgIhlrVdgwfA5N5IaLGr_oDMyYIibrbG5I0H-Q~fef44c467ea4b1fbb4c9314e5a2229da

Upcoming events on Oncology Venture A/S

08/10/2024 Q2 2024 Earnings Release (Projected)
12/11/2024 Q3 2024 Earnings Release (Projected)
19/05/2025 Q4 2024 Earnings Release (Projected)
23/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Oncology Venture A/S

15/05/2024 01:31 am Q1 2024 Earnings Release
01/04/2024 07:30 pm Extraordinary Shareholders Meeting
08/03/2024 05:45 pm Q4 2023 Earnings Release
29/02/2024 Biomarkers Congress
14/11/2023 Biomarkers Europe Congress
19/10/2023 ThinkEquity Conference
23/06/2023 10:30 pm Extraordinary Shareholders Meeting
03/06/2023 06:30 pm American Society of Clinical Oncology Conference - Abstract # 3130
20/03/2023 Extraordinary Shareholders Meeting
03/02/2023 11:30 pm Annual General Meeting
02/12/2022 11:30 pm Annual General Meeting
16/11/2022 02:31 am Q3 2022 Earnings Release
12/10/2022 01:35 am Interim 2022 Earnings Release
30/09/2022 12:30 am Ladenburg Thalmann Healthcare Conference
28/05/2022 03:07 am Q1 2022 Earnings Release
17/05/2022 05:10 am FY 2021 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,12
0,54
-78.12%		0,00
0,15
- 		0,00


0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Million USD		Released
Forecast
Spread 		-9,81
-17,2
42.98%		-9,31
-8,96
-3.88%		0,00


0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-21,8
-17,0
-28.61%		-9,47
-9,13
-3.68%		0,00


-32,7
-31,5
-3.64%		-17,1
-16,7
-2.5%
-23,6

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-25,8
-17,3
-49.27%		-9,33
-7,71
-21.03%		0,00


-17,6
-20,0
12.17%		-11,8
-14,5
18.58%
-16,4

Net income
Million USD		Released
Forecast
Spread 		-20,4
-15,4
-32.08%		-7,53
-6,85
-9.81%		-26,6


-21,1
-20,4
-3.35%		-20,4
-14,5
-40.66%
-16,4

EPS
USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00


-61 880
-60 760
-1.84%		-205
-4 117
95.02%
-2,60

Announcement Date31/03/2031/03/2117/05/2213/03/2308/03/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-4,30
-5,35
19.51%		-4,33
-5,61
22.86%		-4,56
-3,30
-38.43%		-4,97
-4,33
-14.67%		-3,66
-3,63
-0.94%		-4,16
-3,59
-15.9%		-4,43
-3,51
-25.95%		-4,88
-4,47
-9.15%		-4,24
-4,94
14.12%
-5,92


-6,22


-6,53

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-4,31
-5,35
19.42%		-4,65
-5,61
17.09%		-5,03
-2,89
-74.18%		-3,14
-4,38
28.24%		-3,35
-3,63
7.53%		-2,38
-3,59
33.63%		-4,45
-3,51
-26.55%		-1,64
-4,34
62.19%		-3,85
-3,16
-21.78%
-3,10


-5,19


-5,00

Net income
Million USD		Released
Forecast
Spread 		-4,65
-5,35
12.97%		-4,66
-5,61
17.02%		-6,68
-2,89
-131.33%		-3,10
-4,38
29.13%		-3,36
-3,63
7.42%		-9,79
-3,59
-172.89%		-5,55
-3,51
-58%		-1,72
-4,34
60.28%		-3,88
-3,16
-22.82%
-3,10


-5,19


-5,00

EPS
USD		Released
Forecast
Spread 		-15 680
-18 480
15.15%		-14 560
-19 320
24.64%		-19 040
-7 140
-166.67%		-6 440
-11 760
45.24%		-3 544
-6 304
43.78%		-526
-224
-134.85%		-44,8
-163
72.58%
-5,00

-22,1
-1,76
-1157.95%
-0,29


-0,28


-0,27

Announcement Date27/05/2222/08/2214/11/2213/03/2311/05/2314/08/2314/11/2308/03/2414/05/24---

Upcoming sector events for Oncology Venture A/S

24/07/2024 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
25/07/2024 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
25/07/2024 10:30 am ARGENX SE: Q2 2024 Earnings Release
30/07/2024 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Oncology Venture A/S

17/05/2024 04:30 pm AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
16/05/2024 05:16 pm BIOCON LIMITED: Q4 2024 Earnings Release
16/05/2024 10:30 am ZEALAND PHARMA A/S: Q1 2024 Earnings Release
16/05/2024 LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release
15/05/2024 05:35 pm THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
15/05/2024 04:30 pm CABALETTA BIO, INC.: Q1 2024 Earnings Release
15/05/2024 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
15/05/2024 01:35 am ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
15/05/2024 01:30 am ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release
14/05/2024 05:30 pm IMMUNOME, INC.: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. ALLR Stock
  4. Stock
  5. Calendar Oncology Venture A/S